Adlai Nortye Group Ltd. SEC filings ANL
Adlai Nortye Group Ltd. has 114 filings in SEC EDGAR's recent list, going back to Dec 21, 2022. Its latest annual report, Form 20-F, was filed on Apr 10, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 28, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Oct 1, 2026 | Sep 29, 2026 |
| 4 | Insider transaction | Sep 24, 2026 | Sep 22, 2026 |
| 144 | Notice of proposed sale | Sep 18, 2026 | — |
| 4 | Insider transaction | Aug 26, 2026 | Aug 24, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| 3 | Initial insider ownership | Aug 4, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Jul 15, 2026 | Mar 18, 2026 |
| 4 | Insider transaction | Jun 10, 2026 | Dec 16, 2018 |
| 3 | Initial insider ownership | Jun 1, 2026 | May 28, 2026 |
| 3 | Initial insider ownership | May 28, 2026 | Mar 18, 2026 |
| 4 | Insider transaction | May 21, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | May 21, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | May 20, 2026 | Mar 18, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 14, 2026 | — |
| 3/A | Primary document | May 14, 2026 | Mar 18, 2026 |
| 3/A | Primary document | May 8, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | May 8, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Apr 29, 2026 | Mar 18, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 11, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 9, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 20, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 16, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 29, 2025 | — |
| SC 13G | Ownership over 5% (passive) | Mar 4, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 15, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 15, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Jan 31, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Oct 13, 2023 | — |
Showing 31 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ANL (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Singapore
- Headquarters
- Singapore
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1944552
- Former names
- Adlai Nortye Ltd. (until Aug 19, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.